NIH-funded research R01 grant

Dietary DHA to reduce ozone-related lung inflammation

Official title: Dietary DHA mitigates ozone induced pulmonary inflammation

Funded at Ohio State University · NIH-11464926 · Data updated 2026-11-12

A study in mice and humans explores whether consuming DHA, a healthy fat, can lessen lung inflammation caused by ozone exposure, with a focus on people who are overweight or obese.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionOhio State University
NIH-funded
Lab location1 site (Columbus, UNITED STATES)
Project startSeptember 9, 2020
Project endJune 30, 2031
Funding year2026
Award (this year)$792,023
NIH project number2R01ES031378-06
Project IDNIH-11464926 on NIH RePORTER

Who could benefit from this research

Could help

Individuals who have exposure to air pollution or are at risk for ozone-related lung inflammation, including those with obesity or poor dietary DHA intake.

Less likely to help

Healthy individuals with minimal ozone exposure or those unable to safely alter their diet may see no direct benefit.

What this research studies

This grant investigates how increasing dietary DHA affects lung inflammation from ozone exposure, including mechanisms like maresin 1 production and reduced pro-inflammatory fatty acids. The research includes animal models and references early human data showing DHA can lower harmful lipid levels in blood, with a goal of translating findings to people at higher risk. The team will examine how DHA changes alveolar macrophage behavior to promote cleanup of damaged lung cells and improve recovery after exposure. Results could guide dietary recommendations or interventions to protect vulnerable individuals from air pollution effects.

Why it matters

Potential benefit: If successful, it could lead to dietary strategies that reduce lung inflammation and injury from ozone, improving respiratory health in at-risk populations.

How similar studies have gone: Prior work in animals and limited human data suggest DHA can modulate inflammatory pathways and lipid mediators, supporting potential benefit but requiring further validation.

Where this research is happening

  • Ohio State University
    Columbus, United States
    Active

Researchers

  • Principal investigator: Gowdy, Kymberly Mae — Ohio State University
  • Study coordinator: Gowdy, Kymberly Mae

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.